CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Delisting notice
- 4 Grant or award General Counsel and Secretary acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 450,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 750,000 shares (grant or award)
- 424B5 Offering Prospectus
- 8-K/A Event Material agreement
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation
- 4 Returned to the company General Counsel and Secretary returned 120,000 shares (to the company)
- 4 Returned to the company Chief Financial Officer returned 120,000 shares (to the company)
- 4 Returned to the company Chief Executive Officer returned 300,000 shares (to the company)
- 4 Open-market buy General Counsel and Secretary bought 25,000 shares at $0.39 ($9,725)
- 4 Open-market buy Chief Financial Officer bought 40,594 shares at $0.37 ($15,020)
- 4 Open-market buy Chief Executive Officer bought 135,000 shares at $0.38 ($50,625)
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
Page 11 of 41 · 802 filings